NO20075752L - Kimeriske proteiner, deres fremstilling og farmasoytiske sammensetninger som inneholder dem - Google Patents
Kimeriske proteiner, deres fremstilling og farmasoytiske sammensetninger som inneholder demInfo
- Publication number
- NO20075752L NO20075752L NO20075752A NO20075752A NO20075752L NO 20075752 L NO20075752 L NO 20075752L NO 20075752 A NO20075752 A NO 20075752A NO 20075752 A NO20075752 A NO 20075752A NO 20075752 L NO20075752 L NO 20075752L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- chimeric proteins
- chimeric protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Peptides Or Proteins (AREA)
Abstract
SAMMENDRAG Den foreliggende oppfinnelse angår et kimærisk protein som omfatter et cellemålrettende middel og et Yersinia ytre protein, koblet ved et translokerende polypeptid. Oppfinnelsen angår ytterligere fremstilling og anvendelse av slike kimæriske protein.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL16795905 | 2005-04-11 | ||
PCT/IL2006/000456 WO2006109303A2 (en) | 2005-04-11 | 2006-04-10 | Chimeric proteins comprising yersinia yop, their preparation and pharmaceutical compositions containing them |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20075752L true NO20075752L (no) | 2008-01-11 |
Family
ID=36954510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20075752A NO20075752L (no) | 2005-04-11 | 2007-11-09 | Kimeriske proteiner, deres fremstilling og farmasoytiske sammensetninger som inneholder dem |
Country Status (9)
Country | Link |
---|---|
US (1) | US8092806B2 (no) |
EP (1) | EP1871880B8 (no) |
JP (1) | JP5122438B2 (no) |
AU (1) | AU2006233929B2 (no) |
CA (1) | CA2603779C (no) |
ES (1) | ES2389527T3 (no) |
IL (1) | IL186258A0 (no) |
NO (1) | NO20075752L (no) |
WO (1) | WO2006109303A2 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2008296194B2 (en) * | 2007-09-04 | 2013-03-14 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Deletions in domain II of Pseudomonas exotoxin A that reduce non-specific toxicity |
US11246915B2 (en) | 2010-09-15 | 2022-02-15 | Applied Molecular Transport Inc. | Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo |
US20130273092A1 (en) * | 2010-10-22 | 2013-10-17 | Trudeau Institute | Uses of yersinia yope peptide, gene and subparts thereof as a plague vaccine component and assays for yersinia pestis-specific t cells |
JP5976815B2 (ja) * | 2011-09-23 | 2016-08-24 | ヴェストファーリッシュ ヴィルヘルム−ユニバーシテート ミュンスター | 乾癬の治療におけるエルシニア属外部タンパク質M(YopM) |
WO2013041247A1 (en) * | 2011-09-23 | 2013-03-28 | Westfällsche Wilhelms-Universitaet Muenster | Yersinia outer protein m (yopm) in the treatment of psoriasis induced by imiquimod |
EP3265477A4 (en) * | 2015-03-03 | 2019-05-29 | Kahr Medical Ltd | DOUBLE SIGNALING PROTEIN (DSP) FUSION PROTEINS AND METHODS OF USE THEREOF FOR THE TREATMENT OF DISEASES |
CN105203766B (zh) * | 2015-09-29 | 2017-01-11 | 河南省科学院生物研究所有限责任公司 | 一种致病性小肠结肠炎耶尔森氏菌测试条制备方法 |
CN112105376A (zh) | 2018-03-08 | 2020-12-18 | 应用分子运输公司 | 用于经口递送的毒素衍生的递送构建体 |
WO2020096695A1 (en) | 2018-11-07 | 2020-05-14 | Applied Molecular Transport Inc. | Cholix-derived carriers for oral delivery of heterologous payload |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9702191D0 (sv) * | 1997-06-09 | 1997-06-09 | Sven Pettersson | Coposition and methods for the treatment of inflammatory dideases |
WO1999052563A1 (en) * | 1998-04-16 | 1999-10-21 | The Regents Of The University Of California | A method for the targeting of proteins produced by yersinia into the cytosol of eukaryotic cells |
GB0112687D0 (en) * | 2001-05-24 | 2001-07-18 | Microbiological Res Authority | Pharmaceutical use of secreted bacterial effector proteins |
-
2006
- 2006-04-10 JP JP2008506052A patent/JP5122438B2/ja not_active Expired - Fee Related
- 2006-04-10 CA CA2603779A patent/CA2603779C/en not_active Expired - Fee Related
- 2006-04-10 WO PCT/IL2006/000456 patent/WO2006109303A2/en active Application Filing
- 2006-04-10 US US11/911,252 patent/US8092806B2/en not_active Expired - Fee Related
- 2006-04-10 ES ES06728257T patent/ES2389527T3/es active Active
- 2006-04-10 AU AU2006233929A patent/AU2006233929B2/en not_active Ceased
- 2006-04-10 EP EP06728257A patent/EP1871880B8/en active Active
-
2007
- 2007-09-25 IL IL186258A patent/IL186258A0/en unknown
- 2007-11-09 NO NO20075752A patent/NO20075752L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2006109303A3 (en) | 2006-12-07 |
EP1871880B1 (en) | 2012-08-08 |
CA2603779A1 (en) | 2006-10-19 |
AU2006233929A1 (en) | 2006-10-19 |
EP1871880A2 (en) | 2008-01-02 |
US20080287356A1 (en) | 2008-11-20 |
WO2006109303A2 (en) | 2006-10-19 |
ES2389527T3 (es) | 2012-10-29 |
JP5122438B2 (ja) | 2013-01-16 |
AU2006233929B2 (en) | 2012-05-31 |
US8092806B2 (en) | 2012-01-10 |
IL186258A0 (en) | 2008-01-20 |
CA2603779C (en) | 2015-05-19 |
JP2008535514A (ja) | 2008-09-04 |
EP1871880B8 (en) | 2012-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20075752L (no) | Kimeriske proteiner, deres fremstilling og farmasoytiske sammensetninger som inneholder dem | |
NO20062709L (no) | Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller | |
NO20075693L (no) | Modulerende forbindelser av indolamin-2,3-dioksygenase og fremgangsmater for anvendelse av samme | |
EA200802170A1 (ru) | Лиофилизированная композиция терапевтического пептидного антитела | |
MY151036A (en) | Synthesis of (r)-n-methylnaltrexone | |
NO20091413L (no) | WNT-antagonister og deres anvendelse i diagnostiseringen og behandlingen av WNT-medierte forstyrrelser | |
CY1118065T1 (el) | Καινοτομες αμινογλυκοσιδες και χρησεις αυτων στη θεραπεια γενετικων διαταραχων | |
NO20044618L (no) | Dedifferensierte, programmerbare stamceller av monocyttisk opprinnelse og deres fremstilling og anvendelse | |
NO20064584L (no) | Tetrahydropyridoindolderivater | |
EA200870599A1 (ru) | Стабильные препараты лаквинимода | |
EA201000399A1 (ru) | Композиции и способы использования проостровковых пептидов и их аналогов | |
NO20064347L (no) | Substituerte 1,2,3,4-tetrahydroisokinolinderivater | |
GEP20084452B (en) | Sulfonamide derivatives for the treatment of diseases | |
NO20090628L (no) | Pyridizinon derivativater | |
BRPI0418251C1 (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo | |
HK1088840A1 (en) | Stable analogs of glp-1 glp-1 | |
NO20080745L (no) | Nye peptider for anvendelse i behandling av fedme | |
SE0301653D0 (sv) | Novel compounds | |
NO20070487L (no) | 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer. | |
NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
NO20050932L (no) | 1-pyridin-4-yl-ureaderivater | |
EA201070129A1 (ru) | Фармацевтический сухой порошкообразный аэрозольный состав, включающий полипептид, и способ его приготовления | |
EA200801164A3 (ru) | Ингибиторы протеина, активирующего 5-липоксигеназу (flap) | |
IL171914A0 (en) | Variants of il-18bp, their preparation and pharmaceutical compositions containing them | |
NO20073059L (no) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |